Home › Funds › PSP Research LLC › VKTX
PSP Research LLC position in VKTX
VIKING THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 10,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$390K, representing 0.21% of its reported portfolio and ranking #37 among its reported holdings. PSP Research LLC has disclosed VKTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
How PSP Research LLC's VKTX position evolved
PSP Research LLC first disclosed a stake in VKTX in Q4 2025 at 14,714 shares (US$518K). Across 3 filings, PSP Research LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 10,000 shares valued at US$390K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 14.71K | $517.64K | New |
| Q1 2026 | 15.00K | $488.10K | Add |
| Q2 2026 | 10.00K | $390.10K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026